238 related articles for article (PubMed ID: 23941331)
1. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy.
Vashi PG; Gupta D; Lammersfeld CA; Braun DP; Popiel B; Misra S; Brown KC
Nutr J; 2013 Aug; 12():118. PubMed ID: 23941331
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Reece L; Dragicevich H; Lewis C; Rothwell C; Fisher OM; Carey S; Alzahrani NA; Liauw W; Morris DL
Ann Surg Oncol; 2019 Aug; 26(8):2622-2630. PubMed ID: 31123932
[TBL] [Abstract][Full Text] [Related]
3. Perioperative nutritional assessment and interventions in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): A systematic review.
Gearing PF; Hawke JA; Mohan H; Heriot AG; Khan A; Beaumont A; Laing E; Waters PS
Eur J Surg Oncol; 2023 May; 49(5):902-917. PubMed ID: 36872111
[TBL] [Abstract][Full Text] [Related]
4. Parenteral nutrition after cytoreductive surgery for peritoneal malignancy: Should it be administered routinely?
Khan A; Beaumont A; Laing E; Guerra G; Jain A; Warrier S; Heriot A
Clin Nutr ESPEN; 2023 Oct; 57():487-493. PubMed ID: 37739696
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
6. The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing cytoreductive surgery: a retrospective study.
AlTawil E; Kalagi NA; Alzahrani S; Alobeed F; Alshammari S; Bin Traiki T
Front Nutr; 2024; 11():1364959. PubMed ID: 38765813
[TBL] [Abstract][Full Text] [Related]
7. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
Vassos N; Förtsch T; Aladashvili A; Hohenberger W; Croner RS
World J Surg Oncol; 2016 Feb; 14(1):42. PubMed ID: 26912149
[TBL] [Abstract][Full Text] [Related]
8. Use of subjective global assessment and clinical outcomes in critically ill geriatric patients receiving nutrition support.
Atalay BG; Yagmur C; Nursal TZ; Atalay H; Noyan T
JPEN J Parenter Enteral Nutr; 2008; 32(4):454-9. PubMed ID: 18596319
[TBL] [Abstract][Full Text] [Related]
9. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes.
Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V
Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834
[TBL] [Abstract][Full Text] [Related]
10. The influence of preoperative nutritional status on the outcomes of an enhanced recovery after surgery (ERAS) programme for colorectal cancer surgery.
Lohsiriwat V
Tech Coloproctol; 2014 Nov; 18(11):1075-80. PubMed ID: 25216721
[TBL] [Abstract][Full Text] [Related]
11. Decline in nutritional status is associated with prolonged length of stay in hospitalized patients admitted for 7 days or more: A prospective cohort study.
Allard JP; Keller H; Jeejeebhoy KN; Laporte M; Duerksen DR; Gramlich L; Payette H; Bernier P; Davidson B; Teterina A; Lou W
Clin Nutr; 2016 Feb; 35(1):144-152. PubMed ID: 25660316
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center.
Cardi M; Sibio S; Di Marzo F; Lefoche F; d'Agostino C; Fonsi GB; La Torre G; Carbonari L; Sammartino P
Gastroenterol Res Pract; 2019; 2019():2824073. PubMed ID: 31191642
[TBL] [Abstract][Full Text] [Related]
13. Epidural analgesia combined with a comprehensive physiotherapy program after Cytoreductive Surgery and HIPEC is associated with enhanced post-operative recovery and reduces intensive care unit stay: A retrospective study of 124 patients.
Osseis M; Weyrech J; Gayat E; Dagois S; Lo Dico R; Pocard M; Eveno C
Eur J Surg Oncol; 2016 Dec; 42(12):1938-1943. PubMed ID: 27381171
[TBL] [Abstract][Full Text] [Related]
14. Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Devilee RA; Simkens GA; van Oudheusden TR; Rutten HJ; Creemers GJ; Ten Tije AJ; de Hingh IH
Ann Surg Oncol; 2016 Sep; 23(9):2841-8. PubMed ID: 27044447
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
[TBL] [Abstract][Full Text] [Related]
16. Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasis.
Wu X; Li Z; Li Z; Jia Y; Shan F; Ji X; Bu Z; Zhang L; Wu A; Ji J
J Surg Oncol; 2015 Jun; 111(7):840-7. PubMed ID: 25864884
[TBL] [Abstract][Full Text] [Related]
17. Impact of improved nutritional status on survival in ovarian cancer.
Gupta D; Lis CG; Vashi PG; Lammersfeld CA
Support Care Cancer; 2010 Mar; 18(3):373-81. PubMed ID: 19484479
[TBL] [Abstract][Full Text] [Related]
18. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies.
Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E
Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429
[TBL] [Abstract][Full Text] [Related]
19. Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Birgisson H; Enblad M; Artursson S; Ghanipour L; Cashin P; Graf W
Eur J Surg Oncol; 2020 Dec; 46(12):2283-2291. PubMed ID: 32873455
[TBL] [Abstract][Full Text] [Related]
20. Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.
Valle SJ; Alzahrani N; Alzahrani S; Traiki TB; Liauw W; Morris DL
Surg Oncol; 2016 Sep; 25(3):315-20. PubMed ID: 27566038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
